Your browser doesn't support javascript.
loading
Sheng-Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats.
Li, Juan; Zhu, Lv; Zhang, Yu-Mei; Chen, Huan; Miao, Yi-Fan; Kang, Hong-Xin; Ren, Hong-Yu; Wan, Mei-Hua; Long, Dan; Tang, Wen-Fu.
Afiliación
  • Li J; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Zhu L; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Zhang YM; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Chen H; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Miao YF; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Kang HX; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Ren HY; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Wan MH; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Long D; Key Laboratory of Transplant Engineering and Immunology, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Tang WF; Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
Article en En | MEDLINE | ID: mdl-30402130

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Evid Based Complement Alternat Med Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Evid Based Complement Alternat Med Año: 2018 Tipo del documento: Article País de afiliación: China